What Causes Scleroderma? PDF Print E-mail
Monday, 13 September 2010 16:52
Collagen is a group of naturally occurring proteins, found exclusively in animals and especially in the flesh and connective tissues of mammals. It is the main component of connective tissue, and is the most abundant protein in mammals, constituting about 25% to 35% of the whole-body protein content. Beside connective tissue, collagen (in the form of elongated fibrils) is mostly found in fibrous tissues such as tendons and ligaments, and abundant in the cornea, cartilage, bones, blood vessels, the gut, and intervertebral discs.

The connective tissue is the material between the cells of the body that gives tissues form and strength. Fibrous in nature, it is produced by special cells called fibroblasts and made up of dozens of proteins, including collagen (a fibrous protein building block), proteoglycans (a group of proteins that maintain tissue stiffness), and glycoproteins (composed of a protein and a sugar).

Connective tissue also surrounds and supports many of the organs and structures within the body, including the skin, blood vessels, and nerves.

Similarly, many cells of the immune system are found in the connective tissue. In Scleroderma, autoimmunity leads to excessive production and accumulation of collagen in the skin and other connective tissues, causing hardening and scarring (fibrosis). Smaller blood vessels are also damaged, causing many of the complications associated with the disorder, including high blood pressure and the onset of Raynaud's.

Although doctors aren't sure what prompts this abnormal collagen production, the body's immune system plays a significant role. For reasons still unknown, the system turns against the body, attacking the cells (fibroblasts) that produce collagen. Collagen is usually produced in small amounts, but the attack prompts inflammation and the eventual overproduction of the collagen, which replaces normal tissue in the skin and other organs.

Some medical scientists, researchers, and experts assert that Scleroderma is caused by a number of inherited or genetic abnormalities or vulnerabilities, which were triggered by environmental factors, such as a virus, certain adhesive and coating materials, and organic solvents such as vinyl chloride or trichloroethylene. It should be noted however, that research is being conducted to verify these and similar connections.

According to Dr. Laura Hummers and Dr. Fred Wigley, several drugs are used that have in vitro (in the tissue culture) ability to reduce collagen production or to destabilize tissue collagen. The older medications in this category include colchicine, para-aminobenzoic acid (PABA), dimethyl sulfoxide, and D-penicillamine. Although there is evidence for and against the use of these agents, most experts are disappointed with them and believe that the benefit either does not exist or the drug is not potent enough to warrant its use.

The search for new drugs that alter the fibrotic reaction is probably one of the most active areas of Scleroderma research. Strategies include directly suppressing the fibroblast and its ability to make collagen, inhibiting the cytokines that activate the fibroblast, and the use of agents that might break down collagen faster and promote tissue remodeling.

For futher reading, we encourage you to visit some of the sources identified below. You can also login, to download Chapter 23 of Systemic Sclerosis, 2nd Edition written by Dr. Laura Hummers and Dr. Fred Wigley, in which the previous three paragraphs were taken, from the link provided below.

  • A.D.A.M (2009), “Scleroderma”, viewed online at http://nyti.ms/cntoNm
  • Health Grades Inc. (2010), “Causes of Scleroderma”, Wrong Diagnosis; viewed online at http://bit.ly/avwwlq
  • John Hopkins Scleroderma Center (2010), “Scleroderma Treatment Options”, viewed online at http://bit.ly/bCHCbg
  • Mayo Foundation (2010), “Scleroderma”, viewed online at http://bit.ly/9CBlAF
  • Science Daily (2005), “New Clues Into Causes of Scleroderma”, viewed online at http://bit.ly/bXHefF
  • Trafton, A. (2010), “Exposing collagen's double life”, MIT News; viewed online at http://bit.ly/cIkfTc
  • Wellsphere (2010), “Autoimmunity leads to excessive production of collagen in scleroderma”, Wellsphere; viewed online at http://bit.ly/bFhwYn
  • Wikipedia (2010), “Collagen”, viewed online at http://bit.ly/aqzwsH

More articles :

» Patients With Scleroderma May Not Exhibit Increased Corneal Thickness

in patients with systemic sclerosis may not differ significantly from those of healthy patients, contrary to prior hypothesis, a study found."Because [] is characterized by increased deposition of and other connective tissue components in the skin...

» Rituximab Shows Promise in Scleroderma

Rituximab (Rituxan) improved lung function in patients with , a small proof-of-principle study found.At one year, patients randomized to receive rituximab had a median 10.25% increase in forced vital capacity (FVC) compared with baseline, while...

» What Is Autoimmune Hepatitis?

Autoimmune hepatitis is an of the caused by an autoimmune disorder. An autoimmune disorder is one in which a person's immune system attacks his or her own body for unknown reasons. The degree of liver inflammation can range from mild to deadly.The...

» Mouth Exercises For Scleroderma

The loss of facial mobility may restrict the ability to chew foods and perform adequate moth hygiene. Below is some advice on maintaining facial mobility through exercise.INSTRUCTIONS:Do exercises in front of a mirror. Massage (firm touch) the...

» Moves Toward Personalized Medicine for Scleroderma

researchers have received two five-year grants totaling $953,000 from the National Institutes of Health's (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases to study , an autoimmune disease for which there currently is no...

» Our First Year Anniversary

Celebrating an important anniversary is always a blessing. The Scleroderma Care Foundation was officially incorporated on 15th October 2008. Its mission to provide support and education for persons afflicted with within Trinidad and Tobago became a...